Alvotech (ALVO) Revenue (2022 - 2026)
Alvotech's (ALVO) quarterly Revenue came in at $54.8 million in Q2 2026, down 42.25% on a YoY basis from $94.8 million in Q2 2025, and up 6.99% quarter-over-quarter from $51.2 million in Q1 2026.
Analysis
Alvotech (ALVO) Revenue (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Revenue for 5 consecutive years, with $54.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Revenue fell 42.25% year-over-year to $54.8 million; the trailing twelve-month figure through Jun 2026 stood at $343.3 million (up 3.18% YoY), and the FY2025 full-year result was $276.3 million, up 1.02% from the prior year.
- Revenue grew to $54.8 million in Q2 2026 per ALVO's latest filing, from $51.2 million in the prior quarter.
- Across five years, Revenue topped out at $204.7 million in Q4 2025 and bottomed at $3.9 million in Q3 2022.
- Historically, Revenue has averaged $52.1 million across 5 years, with a median of $42.9 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Revenue sank 80.23% in 2023, then soared 784.21% in 2025.
- Over 5 years, Revenue stood at $3.9 million in 2022, then jumped by 380.65% to $18.9 million in 2023, then soared by 248.76% to $65.9 million in 2024, then jumped by 210.62% to $204.7 million in 2025, then sank by 73.25% to $54.8 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $54.8 million, $51.2 million, and $204.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn | 4.14 Bn |
| 2 | Viatris | 19.19 Bn | 18.31 Bn | 1.46 Bn | 3.76 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 852.47 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 796.20 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 543.21 Mn | 2.10 Bn | 2.85 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 54.76 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 266.04 Mn |
| 8 | Amphastar Pharmaceuticals | 993.77 Mn | 703.65 Mn | 93.47 Mn | 183.90 Mn |
| 9 | Fennec Pharmaceuticals | 408.67 Mn | 367.42 Mn | 17.15 Mn | 17.87 Mn |
| 10 | RedHill Biopharma | 179.39 Mn | 179.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.76 Mn |
| Mar 31, 2026 | 51.18 Mn |
| Dec 31, 2025 | 204.73 Mn |
| Sep 30, 2025 | 32.65 Mn |
| Jun 30, 2025 | 94.83 Mn |
| Mar 31, 2025 | 109.91 Mn |
| Dec 31, 2024 | 65.91 Mn |
| Sep 30, 2024 | 62.11 Mn |
| Jun 30, 2024 | 53.48 Mn |
| Mar 31, 2024 | 12.43 Mn |
| Dec 31, 2023 | 18.90 Mn |
| Aug 31, 2023 | 22.72 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Dec 31, 2022 | 3.93 Mn |
| Aug 31, 2022 | 3.93 Mn |
| Jun 30, 2022 | 34.65 Mn |